Last Price
12.30
Today's Change
+0.11 (0.90%)
Day's Change
11.99 - 12.42
Trading Volume
4,988,736
Market Cap
9 Billion
Shares Outstanding
739 Million
Avg Volume
4,727,177
Avg Price (50 Days)
11.14
Avg Price (200 Days)
10.83
PE Ratio
2.15
EPS
5.73
Earnings Announcement
11-Nov-2024
Previous Close
12.19
Open
12.18
Day's Range
11.99 - 12.42
Year Range
8.245 - 13.24
Trading Volume
4,988,736
1 Day Change
0.90%
5 Day Change
0.57%
1 Month Change
20.94%
3 Month Change
17.48%
6 Month Change
10.31%
Ytd Change
8.37%
1 Year Change
5.13%
3 Year Change
23.37%
5 Year Change
18.27%
10 Year Change
18.27%
Max Change
18.27%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.